Jim Simons Decibel Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$2.41 - $4.81 $4,579 - $9,139	1,900 Added 5.85%	34,400 $132,000
Q1 2023 May 12, 2023	SELL	$2.08 - $4.79 $8,099 - $18,652	-3,894 Reduced 10.7%	32,500 $98,000
Q4 2022 Feb 13, 2023	BUY	$1.86 - $3.54 $7,614 - $14,492	4,094 Added 12.67%	36,394 $75,000
Q3 2022 Nov 14, 2022	BUY	$3.82 - $5.61 $17,954 - $26,367	4,700 Added 17.03%	32,300 $112,000
Q2 2022 Aug 12, 2022	BUY	$1.85 - $4.21 $12,367 - $28,143	6,685 Added 31.96%	27,600 $116,000
Q1 2022 May 13, 2022	SELL	$2.83 - $5.03 $84,857 - $150,824	-29,985 Reduced 58.91%	20,915 $64,000
Q4 2021 Feb 11, 2022	BUY	$4.57 - $8.58 $232,613 - $436,722	50,900 New	50,900 $237,000
Q3 2021 Nov 12, 2021	SELL	$6.6 - $9.04 $104,940 - $143,736	-15,900 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.39 - $11.51 $101,601 - $183,009	15,900 New	15,900 $137,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.